Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Thursz, MR; Kwiatkowski, D; Allsopp, C; Hill, B Greenwood AVS; Thomas, HC

doi:10.1042/cs092006Pa

MR Thursz

Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

D Kwiatkowski

Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

C Allsopp

Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

B Greenwood AVS Hill

Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

HC Thomas

Department of Medicine, Imperial College School of Medicine at St Mary's Hospital, Norfolk Place, London, W2 1NY

Search for other works by this author on:

This Site

PubMed

Google Scholar

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

Heterozygote Advantage MHC Class II, but Not Class I, Loci Increases Susceptibility to Persistent HBV Infection

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only